Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data (Frauenherzen)
Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data - A Cross-sectional Study in Apparently Healthy Women Aged 40 to 69 Years (Frauenherzen)
The goal of the clinical trial is to assess whether the data collected from wearable devices can reduce the uncertainty in predicting the cardiovascular disease (CVD) risk in women aged 40-69 years in a situation where information about the blood pressure and blood lipids are unavailable.
Participants will:
- Complete a screening and baseline assessment, including blood sample collection and vital parameter measurement.
- Wear a wearable device for one week.
- Fill in a work and sleep journal.
- Complete a last visit assessment.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Petra Stute, Prof.
- Phone Number: +41 31 632 1010
- Email: petra.stute@insel.ch
Study Locations
-
-
-
Bern, Switzerland, 3010
- Recruiting
- University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
-
Contact:
- Petra Stute, Prof.
- Phone Number: +41 31 632 1010
- Email: petra.stute@insel.ch
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Fluency in German (written and oral).
- Ownership of a smartphone.
- Signing the informed consent form.
Exclusion Criteria:
- Diagnosis of cardiovascular disease.
- Diagnosis of diabetes mellitus.
- Diagnosis of chronic kidney disease.
- Diagnosis of familial hypercholesterolemia.
- Incapable of providing informed consent.
- Current employment at the Section Gynecological Endocrinology and Reproductive Medicine of the Department for Obstetrics and Gynecology at the Inselspital Bern or any other professional relation to one of the study project leaders / investigators.
- Concurrent participation in a clinical intervention study.
- Inability to comply with the study procedures for any reason, including language comprehension, psychiatric illness, general inability to get to the study site.
- Participant's smartphone not compatible with Fitrockr.
- Technical inability of participant's smartphone to connect to the smartwatch.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Apparently healthy women aged 40 to 69 years
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in CVD Risk Prediction Uncertainty Using Wearable Data
Time Frame: After 7-day wearable data collection period.
|
Assessment of the reduction in prediction uncertainty of cardiovascular disease (CVD) risk in women aged 40-69 years when wearable-derived data (e.g., heart rate, daily step count) is used to replace missing physician-recorded inputs (e.g., blood pressure and lipid levels).
The reduction will be quantified using the Continuous Ranked Probability Score (CRPS), whereby smaller CRPS values indicate improved performance.
An improvement is considered substantial if introducing wearable data reduces CRPS by at least 5%.
|
After 7-day wearable data collection period.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of wearable data that improve cardiovascular disease risk prediction without clinical key inputs
Time Frame: After 7-day wearable data collection period.
|
Identifying specific data from wearable devices that most effectively reduce uncertainty in predicting CVD risk in the absence of information on blood pressure, blood lipids, and the presence or absence of metabolic syndrome.
To achieve this, statistical and machine learning methods capable of handling irregularly samples time series of bio-signals recorded by the wearable devices will be applied.
|
After 7-day wearable data collection period.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Petra Stute, Prof., University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022-02080
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.